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Abstract:The aim of this study was to
determine PCNA (Proliferating Cell Nuclear
Antigen) and Ki-67 expression of various soft
tissue sarcomas (STS) immunohistochemically and to correlate with the histologic
grade of these tumors. Retrospectively 185
cases of STS were re-examined. Of the 185
cases, 35 primary STS cases which were
localized in the extremities and trunk wall
were included in this study. Anti-PCNA and
Anti-Ki-67 monoclonal antibodies were
applied to the paraffin sections of tumor
tissues
immunohistochemically.
A
semiquantitative score was employed to
assess the percentage of cells that were
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Introduction
STSs exhibit a wide spectrum of biological behavior.
This variety complicates the determination of prognoses
and the treatment in tumors which are similar
morphologically. In recent years, many multivariate
analyses introducing clinical prognostic features have
shown that the histological grade was the most important
and reliable prognostic factor for STS (1,2).
The grade of malignancy is determined by a combined
assessment of several histological features: mitotic
activity (frequency and abnormality of mitotic figures),
necrosis, cellularity, cellular pleomorphism or anaplasia
(3). However, various technical artefacts restrict the
determination of these criteria crucially and sensitively.
Immunohistochemical methods of assessing cell
proliferation are now becoming popular. In recent years,
many types of monoclonal antibodies which are useful for
the demonstration of cell cycle related antigens
immunohistochemically have been defined (4,5).
In the literature some studies have shown a
correlation between an abundant expression of PCNA and
Ki-67 and unfavorable prognosis in various (cerebral

positively stained. The comparison of the
positively stained tumor cell proportion and
the histologic grade of the tumor was
determined using PCNA (≤ 25%, >25%) and
Ki-67 (≤ 10%, > 10%) indices. A positive
correlation was found between increasing
PCNA and Ki-67 expression and histologic
grade and metastasis.
Our results indicate that PCNA and Ki-67 can
be used as a prognostic factor in STS.
Key Words: Soft tissue sarcomas, PCNA, Ki67, immunohistochemistry.

tumors, breast cancer, malignant lymphoma, STS)
malignancies (5-7). Experience of PCNA and Ki-67
expression in STS is, however, relatively limited.
The present study examines the relationship between
PCNA, Ki-67 expression and histologic grade of various
types of STS.
Materials and Methods
Patients: There were 185 patients who were treated
for primary STS at Çukurova University Faculty of
Medicine 1988-1995. All of these cases of STS were reexamined retrospectively from the files of the Pathology
department. Of these patients 110 (59.5%) were men,
75 (40.5%) were women with a median age of 40.2
years (range 3/12- 85) (The age of 12 patients was not
known).
For this study we selected 35 cases of primary STS.
For the selection of cases we took the following into
consideration: patients with a STS of the extremity and
trunk wall, patients with clinical follow-up, tumors which
are different histological types, the quality of tumor
tissue for immunohistochemistry. In the study group,
261
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there were 20 (57.2%) men and 15 (42.8%) women
with a median age of 44.7 years (range 7- 73) (The age
of one patient was not known). The mean tumor size was
14.6 (range 5-30) cm (information on the tumor size
was not available in seven cases). Twenty-three (65.7%)
tumors were in the lower extremity, four (11.4%) were
in the upper extremity and eight (22.8%) were located
on the trunk wall. Among the patients who had followup, six developed metastases (to lungs in five cases, to
humerus in one case) and three developed recurrence. In
three cases no metastases or recurrence were established
during the follow-up of 4 years. The median follow-up
time for survivors was 2.4 years (range 1-8).
Histotype and malignancy grade: Histologic grading
and classification were made based on the criteria of
Enzinger and Weiss (3). For identification of mitoses, the
number of mitoses per ten high-power fields (HPF)
(x400) were counted separately by two pathologists.
Mitotic counts were done in the most cellular and mitotic
areas. Pyknotic nuclei and suspicious cells were excluded.
Cellularity was estimated and categorized as high,
intermediate and low. In the term of necrosis, all of the
hematoxylin and eosin stained slides with tumor for each
case were examined. The cases were classified into two
groups by each pathologist: less than 50% tumor
necrosis for all the examined tumor surface and tumor
necrosis on more than half of the examined tumor
surface.
Immunohistochemistry: Immunostaining was
performed by the avidin-biotin peroxidase technique
(ImmuStain Strept A-B Universal Kit, DPC/USA).
Negative and positive control slides were used for
each study group.
Evaluation
of
proliferative
activity:
A
semiquantitative score was employed to assess the
percentage of cells that were positively stained with PCNA
and Ki-67 (8,9). The entire specimen area of each slide
examined separately by two pathologists (ÖA, CE) on two
separate occasions at two week intervals randomly
without knowledge of the code. Briefly, the most cellular
and markedly stained parts of the tumors for each slide
were determined on low-power field. To determine the
percentage of positive cells for PCNA and Ki-67, at least
200 cells were counted in two separate HPFs (x400) per
slide. A mean of the two percentages was calculated for
each case and was considered the staining index. In cases
where significant field-to-field variation in the percentage
of positive cells existed, another HPF was examined and a
mean of the three percentages was calculated. The
percentage of PCNA and Ki-67 positive cells was classified
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as ≤10%, 11-25%, 26-50%, >50%. All immunostained
nuclei, independent of intensity, were scored as positive.
The germinal center cells of human tonsil which stained
positively for PCNA and Ki-67 were employed as positive
controls. All of the immunostained slides were evaluated
under a light microscope (Nikon, Optiphot-2).
Statistical analysis: Differences between categorical
variables were determined using the chi-square test and
the SPSSPC program was used for statistical analysis.
Results
The distribution of histologic types and subtypes of
35 cases of STS are shown in Table 1. The number of
mitoses per 10 HPF ranged from two to 40 (median 9.3)
in the tumors of the study group. Tumor necrosis was
absent in 12 (34.3%) tumors, was less than 50.0% for
all the examined tumor surface in 14 (40.0%) tumors
and on more than half of the examined tumor surface in
nine (25.7%) tumors. Cellularity was high in 23
(65.8%), intermediate in seven (20.0%), and low in five
(14.2%). Based on these criteria 16 (45.7%) tumors
were considered overall to be histologic Grade ΙΙΙ, 12
(34.3%) were Grade ΙΙ, 7 (20.0%) were Grade Ι. In
cases with metastasis, one tumor was Grade ΙΙ and five
were Grade ΙΙΙ. Three cases with recurrences were Grade
Ι, ΙΙ and ΙΙΙ. The pattern of nuclear staining was usually
granular with PCNA and predominantly diffusehomogeneous with Ki-67. Some mitotic cells fail to show
any staining especially with PCNA. Rarely cytoplasmic
staining with Ki-67 is observed. The positivity for PCNA
three (10.0%) cases were associated with ≤10%, six
(20.0%) were 11-25%, 15 (50.0%) were 26-50% and
six (20.0%) were >50%. Tumor cells failed to show any
PCNA staining in five cases. Four cases were Grade Ι, and
one was Grade ΙΙ in the PCNA negative group. The
positivity for PCNA was 11.9% in Grade Ι tumors,
32.0% and 39.6% in Grade ΙΙ (Fig 1,2) and Grade ΙΙΙ
tumors (Table 2).
In one case with recurrence the PCNA index was
50.5%. A cut-off point score of 25% was used for the
PCNA index. The differences between tumor stages and
PCNA groups was found to be statistically significant
(p=0.008). This significance was related to Grade ΙΙΙ
tumors (Table 3).
The positivity groups of Ki-67 were four (16.6%)
cases for ≤10%, five (20.8%) for 11-25%, 12 (50.0%)
for 26-50% (Figs 3,4), three (12.6%) for >50%. There
was no Ki-67 staining in 11 tumors. Five cases were
Grade Ι, one was Grade ΙΙ and five were Grade ΙΙΙ in the
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Histologic Types and Subtypes

Number

%

Malignant Fibrous Histiocytoma
-Storiform-pleomorphic
-Inflammatory
-Giant cell
Liposarcoma
-Myxoid
-Pleomorphic
-Round cell
-Mixed
Rhabdomyosarcoma
-Alveolar
-Embryonal
-Pleomorphic
Malignant Peripheral Nerve Sheath Tumor
Leiomyosarcoma
Synovial sarcoma
Fibrosarcoma
Malignant Mesenchymoma
Malignant Hemangiopericytoma
Angiosarcoma

8
6
1
1
8
3
1
1
3
7
3
1
3
4
3
2
2
2
3
1

22.8

11.5
8.5
5.8
5.8
1.0
1.7
2.8

TOTAL

35

100.0

Ki-67 negative group. The Ki-67 positivity was 7.2% in
Grade ΙΙ and 39.2% in Grade ΙΙΙ tumors (Figs 5,6) (Table
4). For Ki-67 staining a significant difference was

Table 1.

Distribution of histologic
types and subtypes of 35
cases of STS.

Figure 1.

Malignant peripheral nerve
sheath tumor, Grade II
(HEx40).

22.8

20.0

observed between Grade Ι and Grade ΙΙ-ΙΙΙ tumors when
there was no significant difference between Grade ΙΙ and
ΙΙΙ tumors. There was 23.7% positivity for Ki-67 in one
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Tumor Grade

PCNA-Positive Cells (%)
11-25
26-50

≤ 10

>50

TOTAL (%)

I
II
III

1
1
1

2
3
1

5
10

2
4

3 (10.0)
11 (36.6)
16 (53.3)

TOTAL (%)

3 (10.0)

6 (20.0)

15 (50.0)

6 (20.0)

30 (100.0)

Table 2.

Distribution of grade and
positivity of 30 cases of
STS stained with PCNA.

Table 3.

Relationship
between
PCNA index and tumor
grade.

Table 4.

Distribution of grade and
positivity of 24 cases of
STS stained with Ki-67.

Figure 2.

Grade
II
Malignant
peripheral nerve sheath
tumor with low numbers
of PCNA staining cells
(x200).

PCNA index (%)
≤ 25
3
4
2

> 25
0
7
14

TOTAL (%)
3 (10.0)
11 (36.6)
16 (53.3)

9 (30.0)

21 (70.0)

30 (100.0)

Tumor Grade
I
II
III
TOTAL (%)

Tumor Grade

≤ 10

Ki-67 Positive Cells (%)
11-25
26-50

P
0.008

> 50

TOTAL (%)

I
II
III

2
2
-

4
1

5
7

3

2 (8.3)
11 (45.8)
11 (45.8)

TOTAL (%)

4 (16.6)

5 (20.8)

12 (50.0)

3 (12.6)

24 (100.0)
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of the cases with recurrences. A cut-off point score of
10% was used for the Ki-67 index as used in some
former studies (8,9). We found the difference between
the Ki-67 index and tumor stages group to be statistically
significant (p=0.002) and this significance was related to
Grade ΙΙΙ tumors (Table 5). The Ki-67 index was >10%
in six (100%) cases with metastasis and in 14 (77.7%)
cases without metastasis. For PCNA the index was >25%
in five (83.3%) cases with metastasis and in 16 (66.6%)
cases without metastasis. The difference was not
statistically significant between the groups.
Discussion
Proliferation and cellular differentiation are inversely
related processes (8). There is a strong correlation
between the proliferation rate of tumors and clinical
outcome. The prognostic importance of the frequency of

Tumor Grade
I
II
III
TOTAL (%)

Ki-67 index (%)
≤ 10
> 10

mitosis as shown in several studies indicates that further
investigation of the cell proliferation in patients with STS
is required (5,10,11). Furthermore, some authors (12)
reported that mitotic counts are not completely reliable or
reproducible, they only reflect one part of the cell cycle
(the mitotic or M-phase). PCNA and Ki-67 are two cell
cycle antigens which are expressed in proliferative states
and they can be demonstrated in tissues using monoclonal
antibodies. In the literature a good correlation has been
shown between PCNA and Ki-67 reactivity and prognoses
in different tumors (carcinomas of the breast, lung,
cervix, colon, as well as malignant lymphomas, brain
tumors and sarcomas) (6,7,13). A significant correlation
has been reported between Ki-67 expression and mitotic
rate in STS (14).
A correlation between PCNA and Ki-67 reactivity and
tumor grade in STS has been detected in different
retrospective studies (8,15,16). Sahin and co-workers

TOTAL (%)

P

0.002

2
2
0

0
9
11

2 (8.3)
11 (45.8)
11 (45.8)

4 (16.6)

20 (83.3)

24 (100.0)

Table 5.

Relationship between Ki67 index and tumor grade.

Figure 3.

Angiosarcoma, Grade II
(HEx 400).
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(17) have reported that the Ki-67 index is low in benign
and Grade Ι tumors, and high in Grade ΙΙ,ΙΙΙ tumors.
Heslin et al. suggested that Ki-67 score is an independent
prognostic molecular marker that predicts distant
metastasis and tumor mortality (18).
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Figure 4.

Grade II Angiosarcoma
with numerous Ki-67
staining cells indicating
high proliferation (x400).

Figure 5.

Grade III Malignant fibrous
histiocytoma (HEx100).

In the present study we also demonstrated a positive
correlation between Ki-67 and PCNA indices and
histologic grade. PCNA index was ≤25% and Ki-67 was
≤10% in all of the Grade Ι tumors (100%). In Grade ΙΙΙ
tumors, the PCNA index was >25% in 87.5% and the Ki-
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Figure 6.

67 index >10% in 100% of tumors. We observed
disparity between Ki-67 and PCNA indices in five tumors.
High PCNA- low Ki-67 indices were demonstrated in four
of these tumors. In previous studies (9) a lack of
correlation between PCNA and Ki-67 expression has been
shown which they attributed to the relatively long halflife of PCNA, methodological problems, histotype
specificity, and inter- and intra-tumoral heterogenity. We
observed low PCNA, high Ki-67 index in one of the Grade
ΙΙΙ malignant fibrous histiocytoma (MFH). Choong and
Åkerman (9) have also surprisingly demonstrated a lack
of correlation between PCNA expression and tumor grade
in their series (n = 185). However, in the study of
Dreinhöfer et al. (19) low PCNA indices have been found
in some of the Grade ΙV -MFH cases with metastases. Hall
et al. noted that the expression of PCNA may be
deregulated in some tumors. Furthermore, Choong and
Åkerman suggested that combining both PCNA and Ki-67
indices as a marker of proliferation is better than with
either index alone (9). Tumor cells fail to show any PCNA
or Ki-67 staining in some cases. In our study, 80.0% of
PCNA negative tumors were Grade Ι. There was no
staining with Ki-67 in 45.4% of the Grade ΙΙΙ tumors.
Two of these cases were incisional biopsy and the tissue
samples were small. Brown (12) noted that most tumors
consist of a heterogeneous cell population within which
there are different proliferations and thus, Ki-67 staining
on a small biopsy may not reflect the predominant
proliferation rate of a tumor.

Grade III Malignant fibrous
histiocytoma with Ki-67
index >10 % (x200).

Swanson et al. (20) have also observed a disparity
between Ki-67 score and histologic grade in some tumors
(synovial sarcoma, leiomyosarcoma, MFH) in their series.
In the same study they noted that there was a similar
disparity in the literature. In our series when the Ki-67
index was 8.0% in one of the Grade ΙΙ synovia lsarcomas,
there was no staining in the other. The immunostaining
has not been observed in some of the mitotic cells,
especially with PCNA. Similarly, in a previous study an
unexplained negativity was observed in the mitotic cells
and the possibility was considered that this was related to
the artefacts of fixation or processing (4).
In many different tissues, including cervical
carcinoma, lung carcinoma, breast carcinoma the
cytoplasmic staining with Ki-67 has been reported. But
the reason for this is not clear. It may represent a crossreaction with an unrelated cytoplasmic epitope or a
genuine detection of the Ki-67 antigen (12).
The histologic type and subtype may be used as a
short-cut to establish the tumor grade. It is accepted that
some of the histologic types and subtypes are high-grade,
and some are low-grade directly (3). In the literature
there are also several studies which evaluated the
proliferative activity of histologic subtypes (19). But
because of the lack of the number of cases we did not
compare histologic subtypes with PCNA and Ki-67
reactivity. In the present study, high PCNA and Ki-67
indices were observed in the cases with metastases and a
correlation was detected between the proliferation indices
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and the presence of metastases. The PCNA index was
>25% in the 83.3 % and the Ki-67 index was >10% in
100% of cases with metastases. Choong et al. have also
observed higher PCNA and Ki-67 indices in 48 MFH cases
with metastases (8,9). There was a reliable clinical
follow-up in only 12 cases of the study group.
Finally, we suggest that immunohistochemical
assessment of cell proliferation is more practical and easy
than the other techniques and may yield better
information in the current prognostic models for STS.

And the data will be more concrete when PCNA and Ki67 values are evaluated by combining the biological
behaviour of tumors in large series with clinical followup.
Correspondence author:
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